Trans-Pacific Technology Fund (TPTF)

Rey is a pioneering health and life insurance provider in Indonesia, established in 2021. It operates on a digital platform designed to offer comprehensive life, health, and critical illness insurance, distinguishing itself from traditional insurance models. Rey emphasizes a holistic approach to healthcare, integrating wellness and preventative care into its offerings while prioritizing the quality of services provided to its members. By leveraging technology, Rey aims to simplify the insurance experience, eliminating cumbersome paper processes and providing a personalized, data-driven approach. The company's mission is to transform the perception of insurance from a mere necessity into a desirable service that enhances the overall well-being of its users. Rey's diverse team is committed to reimagining the life and health insurance landscape in Indonesia, making it more accessible and aligned with the needs of its customers.

Rey is a pioneering health and life insurance provider in Indonesia, established in 2021. It operates on a digital platform designed to offer comprehensive life, health, and critical illness insurance, distinguishing itself from traditional insurance models. Rey emphasizes a holistic approach to healthcare, integrating wellness and preventative care into its offerings while prioritizing the quality of services provided to its members. By leveraging technology, Rey aims to simplify the insurance experience, eliminating cumbersome paper processes and providing a personalized, data-driven approach. The company's mission is to transform the perception of insurance from a mere necessity into a desirable service that enhances the overall well-being of its users. Rey's diverse team is committed to reimagining the life and health insurance landscape in Indonesia, making it more accessible and aligned with the needs of its customers.

Rey is a pioneering health and life insurance provider in Indonesia, established in 2021. It operates on a digital platform designed to offer comprehensive life, health, and critical illness insurance, distinguishing itself from traditional insurance models. Rey emphasizes a holistic approach to healthcare, integrating wellness and preventative care into its offerings while prioritizing the quality of services provided to its members. By leveraging technology, Rey aims to simplify the insurance experience, eliminating cumbersome paper processes and providing a personalized, data-driven approach. The company's mission is to transform the perception of insurance from a mere necessity into a desirable service that enhances the overall well-being of its users. Rey's diverse team is committed to reimagining the life and health insurance landscape in Indonesia, making it more accessible and aligned with the needs of its customers.

Prixa is a pioneering digital healthcare company based in Jakarta, Indonesia, founded in 2019. It offers a comprehensive health management platform that integrates various healthcare services into a single accessible ecosystem. Utilizing artificial intelligence, Prixa provides teleconsultation, doctor appointments, pharmacy delivery, lab tests, and health-related content. The platform caters primarily to healthcare payers, including insurance companies, corporations, and governmental entities, with the aim of humanizing health management and making healthcare more affordable. Through its innovative approach, Prixa enables users to effectively manage their health while reducing claims and overall healthcare costs.

Finch Therapeutics is a biotechnology company based in Somerville, Massachusetts, focused on developing microbial therapies for patients with serious medical needs. The company specializes in creating microbiome-based treatments to address conditions driven by dysbiosis or disruption of the microbiome. Finch Therapeutics offers two main product platforms: Full-Spectrum Microbiota and Rationally-Selected Microbiota, which aim to restore microbiome functionality. These therapies are designed to treat various conditions, including recurrent C. difficile infection, chronic hepatitis B, inflammatory bowel disease, and gastrointestinal symptoms in children with autism. The company employs machine learning algorithms to analyze clinical data from successful fecal transplantations, identifying effective microbial combinations for therapeutic use. Finch Therapeutics was founded in 2017 and has a strong intellectual property portfolio, including over 70 issued patents relevant to microbiome therapeutics.

Finch Therapeutics is a biotechnology company based in Somerville, Massachusetts, focused on developing microbial therapies for patients with serious medical needs. The company specializes in creating microbiome-based treatments to address conditions driven by dysbiosis or disruption of the microbiome. Finch Therapeutics offers two main product platforms: Full-Spectrum Microbiota and Rationally-Selected Microbiota, which aim to restore microbiome functionality. These therapies are designed to treat various conditions, including recurrent C. difficile infection, chronic hepatitis B, inflammatory bowel disease, and gastrointestinal symptoms in children with autism. The company employs machine learning algorithms to analyze clinical data from successful fecal transplantations, identifying effective microbial combinations for therapeutic use. Finch Therapeutics was founded in 2017 and has a strong intellectual property portfolio, including over 70 issued patents relevant to microbiome therapeutics.

Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Founded in 2013 and headquartered in Emeryville, California, Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the efficiency of microbial strain optimization and production processes. This technology enables the company to improve existing manufacturing strains and facilitates the development of new products by engineering novel molecules from microbes. With additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, Zymergen aims to partner with nature to create innovative materials and products that deliver significant value across multiple sectors.

Heal is a healthcare provider focused on delivering value-based, in-home primary care primarily to seniors on Medicare and select Medicare Advantage plans. The company emphasizes the importance of patient comfort by offering services in the familiar environment of patients' homes. Board-certified doctors and nurse practitioners at Heal dedicate ample time to each patient, fostering strong relationships and ensuring thorough, unrushed care. Heal addresses a wide range of healthcare needs, from preventive services like flu shots and annual physicals to the management of chronic conditions and treatment of common illnesses. Additionally, the company provides telemedicine options and remote health monitoring, facilitating easy access to care when needed. Patients can schedule appointments conveniently through phone support, with availability seven days a week, including weekends and holidays.

Kata.ai is an Indonesian company specializing in conversational artificial intelligence, aiming to enhance interactions between humans and machines through advanced natural language processing technology. Founded in 2015, the company has developed a platform that enables businesses to create intelligent chatbots for use in various messaging applications, facilitating automated conversations and improving customer engagement. Its technology has been implemented by major corporations in Indonesia, including Unilever and Telkomsel, across diverse sectors. Kata.ai's proprietary Kata Bot Platform allows organizations of all sizes to easily design and deploy customized chatbots, helping to streamline communication and enhance brand-audience interaction. The company has established partnerships with notable firms such as Microsoft and Accenture, and it secured Series-A funding in 2017 to support its growth and innovation in the AI space.